CM Life Sciences II (OTCMKTS:CMIIU) Major Shareholder Acquires $2,650,000.00 in Stock

CM Life Sciences II Inc. (OTCMKTS:CMIIU) major shareholder Circle 2 Sponsor Corp Columbus acquired 265,000 shares of CM Life Sciences II stock in a transaction on Thursday, February 12th. The stock was acquired at an average cost of $10.00 per share, for a total transaction of $2,650,000.00. Following the completion of the purchase, the insider owned 265,000 shares of the company’s stock, valued at approximately $2,650,000. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

CM Life Sciences II Stock Performance

Shares of CMIIU stock traded down $0.01 during trading hours on Tuesday, reaching $9.99. The company had a trading volume of 93,697 shares, compared to its average volume of 127,266. The company has a 50 day moving average of $11.10 and a 200 day moving average of $11.18. CM Life Sciences II Inc. has a 1-year low of $9.99 and a 1-year high of $10.02.

CM Life Sciences II Company Profile

CM Life Sciences II, Inc is a special purpose acquisition company (SPAC) incorporated in Delaware in February 2021. The company’s units trade on the OTC market under the ticker CMIIU. As a blank‐check company, CM Life Sciences II seeks to identify and acquire one or more businesses in the life sciences industry, including biotechnology, biopharmaceuticals, medical devices and related areas.

The company raised capital through its initial public offering in mid-2021, issuing public units each comprising one share of Class A common stock and a fraction of a warrant.